Benitec Biopharma Inc. (BNTC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Benitec Biopharma Inc.

    NASDAQ: BNTC · Real-Time Price · USD
    13.91
    -0.09 (-0.64%)
    At close: Sep 05, 2025, 3:59 PM
    13.91
    0.00%
    After-hours: Sep 05, 2025, 04:41 PM EDT

    Benitec Biopharma Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 216K 75K 73K 59K
    Cost of Revenue
    		 108K 381K 9K 123K
    Gross Profit
    		 108K -306K 64K -64K
    Operating Income
    		 -22.49M -19.08M -17.85M -13.6M
    Interest Income
    		 904K n/a n/a n/a
    Pretax Income
    		 -21.75M -19.56M -18.21M -13.88M
    Net Income
    		 -21.75M -19.56M -18.21M -13.88M
    Selling & General & Admin
    		 6.99M 6.38M 6.65M 6.51M
    Research & Development
    		 15.61M 12.77M 11.27M 7.02M
    Other Expenses
    		 -216K n/a n/a n/a
    Operating Expenses
    		 22.38M 19.16M 17.92M 13.53M
    Interest Expense
    		 n/a 33K 32K 6K
    Selling & Marketing Expenses
    		 277K n/a n/a n/a
    Cost & Expenses
    		 22.49M 19.16M 17.93M 13.65M
    Income Tax Expense
    		 -619K 3K 354K n/a
    Shares Outstanding (Basic)
    		 10.26M 1.39M 1.92M 1.01M
    Shares Outstanding (Diluted)
    		 10.28M 1.39M 1.92M 1.01M
    EPS (Basic)
    		 -2.68 -14.12 -19.31 -27.27
    EPS (Diluted)
    		 -2.68 -14.12 -19.31 -27.27
    EBITDA
    		 -21.41M -19.15M -17.85M -13.45M
    EBIT
    		 -21.75M -19.53M -18.18M -13.88M
    Depreciation & Amortization
    		 343K 381K 392K 424K

    Add to Watchlist